Exelixis
EXEL
204 hedge funds and large institutions have $2.81B invested in Exelixis in 2016 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 84 increasing their positions, 43 reducing their positions, and 20 closing their positions.
190% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 20
95% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 43
89% more capital invested
Capital invested by funds: $1.48B → $2.81B (+$1.32B)
62% more call options, than puts
Call options by funds: $64.2M | Put options by funds: $39.6M
23% more funds holding
Funds holding: 166 → 204 (+38)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$67.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$33.2M |
| 3 |
Goldman Sachs
New York
|
+$31.7M |
| 4 |
PP
PDT Partners
New York
|
+$30.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$29.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$35M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$25M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.5M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$17.2M |
EXEL Hedge Fund Activity: Q3 2016 in Review
204 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q3 2016, worth a combined $2.81B — up 89% from $1.48B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new EXEL positions and 20 closed out — a net gain of 38 holders — while 84 added to existing stakes and 43 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $67.1M. The largest seller was Millennium Management, cutting an estimated $35M.
- 204 institutional investors held Exelixis (EXEL) as of Q3 2016, up from 166 in Q2 2016.
- Funds reported $2.81B of Exelixis stock for Q3 2016, up 89% quarter-over-quarter.
- 58 funds opened new Exelixis positions in Q3 2016 and 20 closed out, a net change of +38 holders.
- The largest Exelixis buyer in Q3 2016 was OrbiMed, an estimated $67.1M added.
- The largest Exelixis seller in Q3 2016 was Millennium Management, an estimated $35M sold.
Based on aggregated 13F filings for Q3 2016.